XML 64 R46.htm IDEA: XBRL DOCUMENT
v3.26.1

Investments In Affiliated Companies, Partnerships And Other Companies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Abstract] |
Investments In Affiliated Companies |
| December 31, 2025 |  | December 31, 2024
Companies accounted for under the equity method(1) | $ | 113,339 |  |  | $ | 101,145 |
Companies accounted for under the fair value method and other investments(2) | 13,561 |  |  | 24,862 |
| $ | 126,900 |  |  | $ | 126,007 |
(1) See Note 6B. (2) See Note 6C.
Schedule of investments in companies accounted for under the equity method |
| December 31, 2025 |  | December 31, 2024
Company A (1) | $ | 99,102 |  |  | $ | 88,974 |
Company B (2) | 5,634 |  |  | 5,220 |
Company C (3) | 4,147 |  |  | 3,641 |
Other | 4,456 |  |  | 3,310 |
| $ | 113,339 |  |  | $ | 101,145 |
Schedule Of Equity In Net Earnings Of Affiliated Companies | Equity in net earnings of affiliated companies and partnerships is as follows:
| Year ended December 31, 2025 |  | Year ended December 31, 2024 |  | Year ended December 31, 2023
Company A | $ | 25,556 |  |  | $ | 20,492 |  |  | $ | 10,526 |
Company B | 1,088 |  |  | 1,582 |  |  | 1,822 |
Company C | 506 |  |  | 522 |  |  | (93) |
Other | 2,093 |  |  | (3,420) |  |  | 20 |
| $ | 29,243 |  |  | $ | 19,176 |  |  | $ | 12,275 |
Balance Sheet Information | The summarized aggregate financial information of companies accounted for under the equity method is as follows: Balance Sheet Information:
| December 31, 2025 |  | December 31, 2024
Current assets | $ | 368,866 |  |  | $ | 327,961 |
Non-current assets | 147,926 |  |  | 159,219 |
Total assets | $ | 516,792 |  |  | $ | 487,180 |
Current liabilities | $ | 253,886 |  |  | $ | 229,280 |
Non-current liabilities | 59,468 |  |  | 66,165 |
Shareholders' equity | 203,438 |  |  | 191,735 |
Total liabilities and equity | $ | 516,792 |  |  | $ | 487,180 |
Income Statement Information | Income Statement Information:
| Year ended December 31, 2025 |  | Year ended December 31, 2024 |  | Year ended December 31, 2023
Revenues | $ | 455,127 |  |  | $ | 390,225 |  |  | $ | 328,138 |
Gross profit | $ | 161,142 |  |  | $ | 143,055 |  |  | $ | 111,698 |
Net income | $ | 52,792 |  |  | $ | 32,440 |  |  | $ | 10,391 |
Investments accounted for under the fair value method | Investments accounted for under the fair value method are evaluated by applying relevant methods as the market approach with the use of an option pricing method or the earning approach using discounted future cash flows, as follows:
| December 31, 2025 |  | December 31, 2024
Company D (1) | $ | 13,561 |  |  | $ | 13,561 |
Company E (2) | — |  |  | 7,301 |
Company F (3) | — |  |  | 4,000 |
| $ | 13,561 |  |  | $ | 24,862 |
(1) Company D is an Israeli Company held 5% by the Company. During 2025 and 2024 there was no indication of change in Company D fair value. (2) Company E engages in developing surgeon-centered visualization technologies. During 2021, following a third party investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a gain of approximately $4,800. During 2022, the Company invested in Company E $1,400 and following third parties investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a gain of approximately $3,200. During 2023, the Company invested in Company E $3,600 and following third parties investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a loss of approximately $1,300. During 2024 the Company invested in Company E $2,800. The Company re-evaluated the fair value of its holding in Company E and during 2025 and 2024 the Company recognized in other income a loss of approximately$7,300 and $14,900, respectively (See Note 26). (3) Company F is an Israeli company of which the Company owns 25% of the outstanding share capital, which is engaged in the field of tactical ground robotic systems. During the first quarter of 2022 the Company invested $2,000 in Company F. During the last quarter of 2022 the Company re-evaluated its investment in Company F and decreased its value in the amount of approximately $4,000. During 2024 there was no indication of change in Company F fair value. During 2025, the Company sold its holdings in Company F for the proceeds of approximately $16,000, as a result the company recognized a gain of approximately $12,000 (see Note 26).

X
- Definition Tabular disclosure of assets and liabilities of companies accounted for under the equity method. + References No definition available. + Details
Name: | eslt_BalanceSheetInformationTableTextBlock
Namespace Prefix: | eslt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of income statements information of companies accounted for under the equity method. + References No definition available. + Details
Name: | eslt_IncomeStatementInformationTableTextBlock
Namespace Prefix: | eslt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Equity In Net Earnings Of Affiliated [Table Text Block] + References No definition available. + Details
Name: | eslt_ScheduleOfEquityInNetEarningsOfAffiliatedTableTextBlock
Namespace Prefix: | eslt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Investments Accounted For Under The Fair Value Method + References No definition available. + Details
Name: | eslt_ScheduleOfInvestmentsAccountedForUnderTheFairValueMethodTableTextBlock
Namespace Prefix: | eslt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investments in and advances to affiliates. Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration